News Daily News Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis Todd Neale August 13, 2025
News Daily News Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced Michael O'Riordan September 20, 2024
News Daily News ORBITA-STAR Highlights Variability in Symptom Changes Post-PCI Michael O'Riordan July 01, 2024
News Daily News Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective Michael O'Riordan February 23, 2024
News Daily News Two ‘Evidence-Based Pathways’ for Stable Angina: ORBITA-2 Editorial Michael O'Riordan December 27, 2023
News Daily News Radial Access Is Safe, Effective for Peripheral Interventions: R2P Registry Todd Neale October 16, 2023
News Daily News COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK Michael O'Riordan September 15, 2022
News Daily News ORBITA Data Undercut the Idea PCI Does Best in Focal CAD Caitlin E. Cox August 06, 2021
News Daily News Add-on CMS Payment Sweetens Shockwave Choice, but Cost Still Rankles Michael O'Riordan May 12, 2021
News Daily News Large UK Study Explores Use of Excimer Laser Coronary Atherectomy Todd Neale September 25, 2020
News Daily News Document Proposes Procedure Volumes to Attain Competency in High-risk PCI Todd Neale September 22, 2020
News Daily News PCI for Preventing Death in Unstable vs Stable CAD: New Data, More Soul-searching Shelley Wood February 19, 2020
News Daily News ‘Immediate’ Return to Normal Flow Post-PCI in ORBITA-Like Patients Michael O'Riordan August 23, 2018